Duke University Health System
Duke University Health System
888-275-3853
Innovative Treatment for Blood- and Lymphoid-Related Cancers
The Duke Hematologic Malignancies Program combines state-of-the-art, compassionate medical care with innovative science to improve outcomes for patients battling leukemias, lymphomas, myelomas, and other blood- and lymphoid-related cancers, including many rare cancers.
The program’s highly experienced team of caregivers provides individualized, hands-on medical attention to each of the nearly 1,000 patients we see each year.
Our nationally reputed medical oncologists, surgeons, radiation oncologists, and stem and marrow transplantation specialists work together to plan a comprehensive treatment strategy for each patient, drawing on the most effective therapies -- including many that have been developed and refined right here at Duke.
Copyright © 2004-2009 Duke University Health System
Votes:33
Comments: 0